Though mortality rates for uterine cancer are on the rise, research for this cancer is underfunded, a study suggests.
Caleb Rans
Contributing Writer
Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.
